Job Title: Medical Representative – Obesity Business Unit
Department: Obesity Business Unit, International Operations
Job Category: Sales
Location: Dubai and NE, United Arab Emirates
Your impact begins here
As Medical Representative in the Obesity Business Unit, you will bring Novo Nordisk’s obesity strategy to life in your territory. Through clear, scientifically grounded con-versations with specialists, physicians and pharmacies, you will help healthcare professionals get the information and support they need. You will turn customer insights into focused territory actions that drive sustainable growth. Your impact shows up in trusted relationships, stronger results and better support for people living with obesity.
What you’ll bring
Useful, but not essential:
Who you’ll work with
You will join the Obesity Business Unit within International Operations, where colleagues work across markets to serve people around the world and help improve health at scale. You will report to Associate Sales Manager Mohamed Mohran
Day to day, your closest partners will be the specialists, physicians, pharmacies and distributors in your territory. Inside Novo Nordisk, you will work alongside fellow Medical Representatives and colleagues across functions, sharing what you learn in the field so the team can act on it quickly. When things stall, you speak up; when a decision is made, you move forward with the team.
What you can expect here
You will be trusted to own your territory, with clear performance expectations and a culture that recognises results. You will deepen your scientific knowledge in obesity, sharpen your commercial skills and grow with colleagues on the job and through relevant learning offerings.
Your voice matters here. Your insights from customer conversations help shape how the team works, and you will be supported to perform at your best while never compromising on quality, ethics or patient safety.
There is, of course, more on offer here than the uniqueness of our culture and the extraordinary results we produce. Being part of a global healthcare company means opportunities to learn and develop are all around us, while our benefits are designed with your career and life stage in mind.
Learn more about our Reward Philosophy here
Start now
Your impact begins today. If you are ready to turn scientific conversations into real progress for people living with obesity, apply for the Medical Representative – Obesity Business Unit role by 9 October 2026.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html